Benzinga's Top Initiations - Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Barclays initiated coverage on Mellanox Technologies, Ltd.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: MLNX) with a Overweight rating. The target price for Mellanox Technologies is set to $58. Mellanox Technologies shares closed at $49.49 on Wednesday.Analysts at Morgan Stanley initiated coverage on MacroGenics Inc (NASDAQ: MGNX) with a Equal-weight rating. The target price for MacroGenics is set to $20. MacroGenics shares closed at $15.74 on Wednesday.Analysts at Stifel Nicolaus initiated coverage on Cohu, Inc. (NASDAQ: COHU) with a Hold rating. Cohu shares closed at $11.97 on Wednesday.Analysts at Compass Point initiated coverage on Evertec Inc (NYSE: EVTC) with a Buy rating. The target price for Evertec is set to $17. Evertec shares closed at $11.50 on Wednesday.Analysts at Citigroup initiated coverage on Biogen Inc

Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.

(NASDAQ: BIIB) with a Buy rating. Biogen shares closed at $257.22 on Wednesday.SunTrust Robinson Humphrey initiated coverage on

Boston Scientific Corporation (NYSE: BSX) with a Buy rating. Boston Scientific shares closed at $17.33 on Wednesday.Analysts at Citigroup initiated coverage of Amgen, Inc. (NASDAQ: AMGN) with a Neutral rating. Amgen shares closed at $147.11 on Wednesday.B. Riley initiated coverage on MCBC Holdings Inc (NASDAQ: MCFT) with a Buy rating. MCBC Holdings shares closed at $12.57 on Wednesday.Analysts at Empire Asset Management CO initiated coverage on Insulet Corporation (NASDAQ: PODD) with a Sell rating. The target price for Insulet is set to $15. Insulet shares closed at $29.26 on Wednesday.Goldman Sachs initiated coverage of ConAgra Foods Inc (NYSE: CAG) with a Neutral rating. ConAgra Foods shares closed at $41.98 on Wednesday.